Johnson & Johnson announces positive results from phase 3 MajesTEC-9 study of Tecvayli in patients with multiple myeloma: Raritan, New Jersey Friday, January 16, 2026, 10:00 Hrs [ ...
Early initiation of an intensive blood pressure control reduced the risk for MACE among older patients with hypertension.
The recommendation comes as school districts across the state grapple with budget deficits and calls grow louder for big ...
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a new collaboration with NVIDIA to accelerate the development of Natera’s multimodal AI ...
A massive new longitudinal study conducted in South Korea indicates that obesity is a risk factor for the development of ...
You don't have to abandon the party platter to protect your heart; cardiologists reveal how one crunchy addition can neutralize sodium and relax your arteries.
On average, national parks throughout the United States receive 318 million visitors each year, according to the National ...
The military’s new height to waist standards aim to better measure health and readiness, but raise concerns about fairness, ...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera® (zanidatamab-hrii) in combination with ...
One of this era’s key questions in economics and finance has been - will the USD maintain its reserve status, and what does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback